World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: TCTR
Last refreshed on: 29 April 2024
Main ID:  TCTR20150629004
Date of registration: 29/06/2015
Prospective Registration: No
Primary sponsor: Siriraj Skin Laser Center
Public title: High versus moderate energy use of bipolar fractional radiofrequency in the treatment of acne scars : A split-face double-blinded randomized control trial pilot study.
Scientific title: High versus moderate energy use of bipolar fractional radiofrequency in the treatment of acne scars : A split-face double-blinded randomized control trial pilot study.
Date of first enrolment: 01/11/2013
Target sample size:
Recruitment status: Completed
URL:  https://www.thaiclinicaltrials.org/show/TCTR20150629004
Study type:  Interventional
Study design:  Randomized  
Phase:  Phase 2
Countries of recruitment
Contacts
Name: weeranut -   phothong
Address:  siriraj hospital 10700 bangkok Thailand
Telephone: +6624199933
Email: weeranut@gmail.com
Affiliation:  mahidol university
Name: weeranut -   phothong
Address:  siriraj hospital 10700 bangkok thailand
Telephone: +6624199933
Email: weeranut@gmail.com
Affiliation:  mahidol university
Key inclusion & exclusion criteria
Inclusion criteria: Fitzpatrick skin phototype III-IV
mild to moderate acne scar
age 18-60

Exclusion criteria: history of prior topical retinoic acid within 6 months
history of prior laser therapy within 3 months
pregnancy
lactation
history of systemic steroid use within 6 months


Age minimum: 18 Years
Age maximum: 60 Years
Gender: Both
Health Condition(s) or Problem(s) studied
acne scar
acne scar
acne scar
Intervention(s)
Experimental Device,Experimental Device
hi energy bipolar fractional radiofrequency,moderate energy bipolar fractional radiofrequency
high energy of fractional radiofrequency (100mJ/pin),moderate energy of fractional radiofrequency (60mJ/pin)
Primary Outcome(s)
efficacy baseline, 1, 3 and 6 month GASS scale
Secondary Outcome(s)
adverse reaction baseline, 1, 3 and 6 month ordinal scale
Secondary ID(s)
DHF10941
Source(s) of Monetary Support
Mahidol University
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Results
Results available:
Date Posted:
Date Completed: 26/08/2014
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history